ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
INSU Acquisition Corporation III

INSU Acquisition Corporation III (IIII)

10,08
0,00
( 0,00% )
Aktualisiert: 01:00:00

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
10,08
Gebot
10,05
Fragen
10,09
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
10,08
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

IIII Neueste Nachrichten

INSU Acquisition Corp. III Announces it Will Redeem its Public Shares

PHILADELPHIA, PA, Nov. 18, 2022 (GLOBE NEWSWIRE) --  INSU Acquisition Corp. III (NASDAQ:IIII) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or...

Cohen & Company Reports Third Quarter 2021 Financial Results

PHILADELPHIA and NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in fixed income markets and, more recently, in...

INSU Acquisition Corp. III Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on F...

PHILADELPHIA, PA, June 04, 2021 (GLOBE NEWSWIRE) -- INSU Acquisition Corp. III (NASDAQ: IIII) (the “Company”), a blank-check company sponsored by Cohen & Company Inc. (NYSE American: COHN...

Cohen & Company Reports Fourth Quarter & Full Year 2020 Financial Results

Fourth Quarter Net Income Attributable to Cohen & Company Inc. of $14.8 Million, or $7.64 per Diluted Share Fourth Quarter Adjusted Pre-Tax Income of $23.8 Million, or $4.64 per Diluted Share...

INSU Acquisition Corp. III Class A Common Shares and Warrants to Commence Trading Separately on February 8, 2021

PHILADELPHIA, PA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- INSU Acquisition Corp. III (NASDAQ:IIIIU) (the “Company”), a blank-check company sponsored by Cohen & Company Inc. (NYSE American: COHN...

Cohen & Company and INSU Acquisition Corp. III Announce Completion of INSU Acquisition Corp. III $250,000,000 Initial Public ...

PHILADELPHIA, PA, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN) and INSU Acquisition Corp. III (NASDAQ:IIIIU) today announced that INSU Acquisition Corp. III...

INSU Acquisition Corp. III Announces Pricing of Upsized $218,000,000 Initial Public Offering

PHILADELPHIA, PA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- INSU Acquisition Corp. III (NASDAQ:IIIIU) (the “Company”), a blank-check company sponsored by Cohen & Company (NYSE American: COHN) and...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

IIII - Frequently Asked Questions (FAQ)

What is the current INSU Acquisition Corpora... share price?
The current share price of INSU Acquisition Corpora... is US$ 10,08
What is the 1 year trading range for INSU Acquisition Corpora... share price?
INSU Acquisition Corpora... has traded in the range of US$ 0,00 to US$ 0,00 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SLXNSilexion Therapeutics Corporation
US$ 1,14
(96,55%)
181,5M
RNAZTransCode Therapeutics Inc
US$ 13,37
(95,75%)
22,27M
YIBOPlanet Image International Ltd
US$ 4,81
(56,17%)
50,21M
TRIBTrinity Biotech PLC
US$ 1,1001
(44,75%)
101,18M
TOIIWOncology Institute Inc
US$ 0,043
(43,33%)
15,66k
LPTXLeap Therapeutics Inc
US$ 0,6498
(-71,12%)
8,62M
STSSSharps Technology Inc
US$ 0,4278
(-70,70%)
12,68M
SABSSAB Biotherapeutics Inc
US$ 2,24
(-48,62%)
959,55k
INKTMiNK Therapeutics Inc
US$ 4,5601
(-48,41%)
116,09k
MGOLMGO Global Inc
US$ 0,168717
(-40,38%)
16,59M
NVDANVIDIA Corporation
US$ 124,785
(5,37%)
292,68M
HEPAHepion Pharmaceuticals Inc
US$ 0,2221
(34,61%)
239,97M
SLXNSilexion Therapeutics Corporation
US$ 1,14
(96,55%)
181,5M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4924
(19,49%)
159,43M
TRIBTrinity Biotech PLC
US$ 1,1001
(44,75%)
101,18M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht